Inventor
VAUGHN ERIC MARTIN
US33 patents
⚠️ This page may combine multiple inventors who share the name “VAUGHN ERIC MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM VETMEDICA GMBH
11 patentsUS10039821B2Aug 7, 2018
European PRRSV strain
BOEHRINGER INGELHEIM VETMEDICA GMBH2 citations70
US10485866B2Nov 26, 2019
Vaccine against porcine parvovirus
BOEHRINGER INGELHEIM VETMEDICA GMBH3 citations68
US10905756B2Feb 2, 2021
Bivalent swine influenza virus vaccine
BOEHRINGER INGELHEIM VETMEDICA GMBH4 citations67
US11261464B2Mar 1, 2022
Promoters
BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations56
US10329586B2Jun 25, 2019
Canine adenovirus vectors
BOEHRINGER INGELHEIM VETMEDICA GMBH1 citations56
US11384365B2Jul 12, 2022
EHV with inactivated UL18 and/or UL8
BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations50
US10660952B2May 26, 2020
Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations50
US10668144B2Jun 2, 2020
European PRRSV strain
BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations49
US10799578B2Oct 13, 2020
Vaccine against porcine parvovirus
BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations48
US11858962B2Jan 2, 2024
Polypeptides useful for detecting anti-rhabdovirus antibodies
BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations47
US10029005B2Jul 24, 2018
Bivalent swine influenza virus vaccine
BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations46
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC
9 patentsUS10555994B2Feb 11, 2020
PCV2 ORF2 carrier platform
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC3 citations72
US11858963B2Jan 2, 2024
PCV2 ORF2 protein variant and virus like particles composed thereof
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC2 citations71
US10961281B2Mar 30, 2021
PCV2 ORF2 protein variant and virus like particles composed thereof
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC3 citations71
US11179457B2Nov 23, 2021
Senecavirus a immunogenic compositions and methods thereof
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC2 citations68
US12247051B2Mar 11, 2025
PCV2 ORF2 protein variant and virus like particles composed thereof
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC0 citations61
US10702601B2Jul 7, 2020
Porcine epidemic diarrhea virus vaccine
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC1 citations60
US10767213B2Sep 8, 2020
Quantification of vaccine compositions
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC1 citations59
US12150983B2Nov 26, 2024
Porcine coronavirus vaccines
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC0 citations55
US10545148B2Jan 28, 2020
Marker system, in particular for baculovirus-expressed subunit antigens
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC0 citations50
BOEHRINGER INGELHEIM VETMEDICA INC
5 patentsUS10131696B2Nov 20, 2018
PCV2 ORF2 protein variant and virus like particles composed thereof
BOEHRINGER INGELHEIM VETMEDICA INC6 citations82
US9950061B2Apr 24, 2018
Porcine epidemic diarrhea virus vaccine
BOEHRINGER INGELHEIM VETMEDICA INC5 citations82
US10168330B2Jan 1, 2019
Marker system, in particular for baculovirus-expressed subunit antigens
BOEHRINGER INGELHEIM VETMEDICA INC2 citations71
US9833507B2Dec 5, 2017
Porcine parvovirus 5A, methods of use and vaccine
BOEHRINGER INGELHEIM VETMEDICA INC0 citations49
US9827306B2Nov 28, 2017
Porcine parvovirus 5B, methods of use and vaccine
BOEHRINGER INGELHEIM VETMEDICA INC0 citations49